Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines.

Edina KaraiKornélia SzebényiTímea WindtSára FehérEszter SzendiValéria DékayPéter VajdovichGergely SzakácsAndrás Füredi

Published in: Cancers (2020)

Our findings suggest that celecoxib could significantly improve the efficiency of chemotherapy by preventing the development of MDR in B-cell lymphoma.

Keyphrases

diffuse large b cell lymphoma
high glucose
multidrug resistant
drug delivery
locally advanced
cancer therapy
mouse model
squamous cell carcinoma
radiation therapy